TMC Life Sciences (0101.KU) - Malaysia (4th) quarter ended Jun 30: Figures Are In Ringgit (MYR). 2025 2024 Revenue 93,273,000 74,124,000 PreTax Profit 3,054,000 341,000 Net Profit 2,423,000 1,024,000 Earnings Per Share 0.14 Sen 0.06 Sen Dividend 0.19 Sen 2.22 Sen 12 months ended Jun 30: Revenue 345,538,000 346,418,000 PreTax Profit 7,072,000 52,621,000 Net Profit 3,606,000 40,648,000 Earnings Per Share 0.21 Sen 2.33 Sen Dividend 0.19 Sen 2.22 Sen
(END) Dow Jones Newswires
August 26, 2025 06:36 ET (10:36 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.